Long-term sustained clinical remission after stopping first-line anti-TNF agents in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis: clinical effectiveness
Canadian Agency for Drugs and Technologies in Health (CADTH)
Record ID 32015000819
English
Authors' recommendations:
Two randomized controlled trials (RCTs) and one non-randomized study were identified regarding the long-term clinical effectiveness (not necessarily clinical remission) in patients with RA who remain on MTX after using an anti-TNF agent plus MTX as first-line treatment.
Details
Project Status:
Completed
Year Published:
2014
URL for published report:
http://www.cadth.ca/sites/default/files/pdf/htis/nov-2014/RB0749%20Anti-TNF%20Agents%20as%20First%20Line%20Treatment%20Final.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Arthritis
- Methotrexate
- Spondylitis
- Dermatology
Contact
Organisation Name:
Canadian Agency for Drugs and Technologies in Health
Contact Address:
600-865 Carling Avenue, Ottawa, ON K1S 5S8 Canada. Tel: +1 613 226 2553; Fax: +1 613 226 5392;
Contact Name:
requests@cadth.ca
Contact Email:
requests@cadth.ca
Copyright:
Canadian Agency for Drugs and Technologies in Health (CADTH)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.